Evofem Biosciences's total assets for Q1 2026 were $7.44M, a decrease of -63.29% from the previous quarter. EVFM total liabilities were $80.15M for the fiscal quarter, a -10.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.